You are using an older browser version. Please use a supported version for the best MSN experience.

We're bring back these psychedelic drugs, 'but as a medical treatment against various forms of mental health issues': atai Life Sciences Founder

Christian Angermayer, atai Life Sciences Founder & Chairman, joined Yahoo Finance Live to break down atai's public debut on the Nasdaq and the future of the psychedelic sector.

UP NEXT

UP NEXT

More From Yahoo! Finance

More From Yahoo! Finance

image beaconimage beaconimage beacon